|
MMP7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.548200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.871500E-02 |
| Normal-vs-Stage2 |
6.029700E-02 |
| Normal-vs-Stage3 |
1.228830E-01 |
| Normal-vs-Stage4 |
8.862200E-02 |
| Stage1-vs-Stage2 |
4.960200E-01 |
| Stage1-vs-Stage3 |
5.999600E-01 |
| Stage1-vs-Stage4 |
5.158800E-01 |
| Stage2-vs-Stage3 |
9.953000E-01 |
| Stage2-vs-Stage4 |
9.033400E-01 |
| Stage3-vs-Stage4 |
9.164200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.726000E-02 |
| Normal-vs-AfricanAmerican |
1.129600E-02 |
| Normal-vs-Asian |
6.332000E-01 |
| Caucasian-vs-AfricanAmerican |
8.208400E-02 |
| Caucasian-vs-Asian |
6.796200E-01 |
| AfricanAmerican-vs-Asian |
3.773200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.478200E-02 |
| Normal-vs-Female |
1.038090E-02 |
| Male-vs-Female |
9.822100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.062300E-02 |
| Normal-vs-Extreme_Weight |
7.814300E-02 |
| Normal-vs-Obese |
3.096400E-02 |
| Normal-vs-Extreme_Obese |
6.872200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.313800E-01 |
| Normal_Weight-vs-Obese |
8.552800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.424700E-03 |
| Extreme_Weight-vs-Obese |
1.854010E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.477850E-02 |
| Obese-vs-Extreme_Obese |
2.279500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.199160E-01 |
| Normal-vs-Age(41-60Yrs) |
3.111800E-02 |
| Normal-vs-Age(61-80Yrs) |
5.750300E-02 |
| Normal-vs-Age(81-100Yrs) |
7.250200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.911800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.780200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.935830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.496600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.946000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.392010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.420120E-02 |
| Normal-VS-Type2 PRCC |
3.712200E-01 |
| Normal-VS-KIRP CIMP |
1.702240E-01 |
| Normal-VS-Unclassified PRCC |
8.018900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.456600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.575600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.062200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.154000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.458100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.941200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.283600E-01 |
| Normal-vs-N1 |
2.445800E-02 |
| Normal-vs-N2 |
1.775590E-01 |
| N0-vs-N1 |
7.417600E-02 |
| N0-vs-N2 |
2.090200E-01 |
| N1-vs-N2 |
1.143630E-01 |
|
|
